Fast relapse upon discontinuation of tumour necrosis factor blocking therapy in patients with peripheral spondyloarthritis-Reference-Cited by-同舟云学术

Fast relapse upon discontinuation of tumour necrosis factor blocking therapy in patients with peripheral spondyloarthritis

Published:2013-05-09 Issue:9 Volume:72 Page:1581-1582
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Paramarta Jacqueline E,Heijda Tanja F,Baeten Dominique L

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference9 articles.

2. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis;Paramarta;Ann Rheum Dis

3. Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab;Baraliakos;Arthritis Res Ther,2005

4. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis;Brandt;Arthritis Rheum,2003

5. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis;Brandt;Rheumatology (Oxford),2005

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To taper or not to taper biological disease-modifying antirheumatic drugs in axial spondyloarthritis anno 2023: That is the question;Best Practice & Research Clinical Rheumatology;2023-09

2. De behandeling van perifere spondyloartritis in 2020;Tijdschrift voor Geneeskunde;2021-01-28

3. Peripheral spondyloarthritis: a neglected entity—state of the art;RMD Open;2020-05

4. Biologic Treatment of Axial Spondyloarthritis;Axial Spondyloarthritis;2019

5. High Rate of Drug-Free Remission After Induction Therapy With Golimumab in Early Peripheral Spondyloarthritis;Arthritis & Rheumatology;2018-10-26